<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="http://wiki.websomething.com/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://wiki.websomething.com/feed.php">
        <title>Websomething Wiki case_study_on_tianeptine_raw_powder</title>
        <description></description>
        <link>http://wiki.websomething.com/</link>
        <image rdf:resource="http://wiki.websomething.com/lib/tpl/dokuwiki/images/favicon.ico" />
       <dc:date>2026-08-15T09:48:45+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://wiki.websomething.com/doku.php?id=case_study_on_tianeptine_raw_powder:mechanisms_efficacy_and_safety&amp;rev=1773719651&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="http://wiki.websomething.com/lib/tpl/dokuwiki/images/favicon.ico">
        <title>Websomething Wiki</title>
        <link>http://wiki.websomething.com/</link>
        <url>http://wiki.websomething.com/lib/tpl/dokuwiki/images/favicon.ico</url>
    </image>
    <item rdf:about="http://wiki.websomething.com/doku.php?id=case_study_on_tianeptine_raw_powder:mechanisms_efficacy_and_safety&amp;rev=1773719651&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-03-17T03:54:11+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>case_study_on_tianeptine_raw_powder:mechanisms_efficacy_and_safety</title>
        <link>http://wiki.websomething.com/doku.php?id=case_study_on_tianeptine_raw_powder:mechanisms_efficacy_and_safety&amp;rev=1773719651&amp;do=diff</link>
        <description>Introduction

Tianeptine is an atypical antidepressant that has gained attention for its unique mechanism of action and potential benefits in treating various mood disorders. Originally developed in the 1960s in France, Tianeptine is classified as a selective serotonin reuptake enhancer (SSRE) rather than a reuptake inhibitor, which distinguishes it from traditional antidepressants. This case study explores the properties, efficacy, safety, and clinical applications of</description>
    </item>
</rdf:RDF>
